Wataru Matsumiya

5PUBLICATIONS
6CO-AUTHORS
AutoimmunityOptical technologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 14, 2023
Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration.

Rei Sotani, Wataru Matsumiya, Kyung Woo Kim

|Mar 27, 2023
Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age-related macular degeneration.

Rei Sotani, Wataru Matsumiya, Kyung Woo Kim

|Sep 21, 2022
Electroretinographic findings in retinal vasculitis.

Hashem H Ghoraba, Wataru Matsumiya, Christopher Or

|Jun 14, 2021
Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia.

Daiki Sakai, Wataru Matsumiya, Sentaro Kusuhara

|Nov 09, 2018
The 24-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Shunichiro Nakai, Wataru Matsumiya, Otsuka Keiko

Pageof 1